Recon: Pharma's rep down again; Roche ponies up $3B for Shape's RNA editing tech

ReconReconAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsDiagnostics/IVDsGlobalMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development